Our molecular docking analysis, which demonstrated strong binding between PCBs and EZH2, hypothesizes that PCBs exposure could potentially influence EZH2’s oncogenic activity, possibly leading to epigenetic modifications that promote tumor growth and therapy resistance. This evidence concerns the gene EZH2 and neoplasm.